
Healthcare · NSE / BSE
Global Health Limited is one of the largest private multi-speciality tertiary care providers in North and East India, operating under the "Medanta" brand. The company specializes in cardiology, neurosciences, oncology, digestive sciences, orthopaedics, liver transplants, and kidney care. With hospitals in Gurugram, Indore, Ranchi, and Lucknow, it offers healthcare services across 30 medical specialities with over 1,300 doctors and 2,467 installed beds. Medanta’s Gurugram hospital was ranked India’s best private hospital from 2020 to 2022 and featured in Newsweek’s global hospital rankings. The company emphasizes clinical research, academic excellence, and advanced medical infrastructure. Its strong financial performance, presence in high-demand areas, and expansion into digital health contribute to its growth. Backed by experienced management and institutional investors, Global Health Limited continues to strengthen its position in India's healthcare sector.
Price Band
₹336
Issue Size
₹2206 Cr
Lot Size
44 shares
GMP
+9.8%
Est. Listing
₹369
at current GMP
Subscribed
9.58x
overall
Open
3 Nov 2022
Close
7 Nov 2022
Allotment
11 Nov 2022
Refund
12 Nov 2022
Demat Credit
13 Nov 2022
Listing
16 Nov 2022
Overall Subscription
9.58x
Total Demand
QIB Multiplier
0.00x
Institutions & Funds
NII / HNI
0.00x
High Net-Worth
Retail (RII)
0.00x
Individual Bidders
Live bidding breakdown by institutional, non-institutional, and retail investors
| Category | Shares Offered | Shares Applied / Bid | Times Subscribed |
|---|---|---|---|
| Qualified Institutional (QIB) | 32,820,982 | — | 0.00x |
| Non-Institutional (NII / HNI) | 9,846,295 | — | 0.00x |
| Retail Individual (RII) | 22,974,687 | — | 0.00x |
| Total | 65,641,964 | 0 | 9.58x |
Total unique applications received across retail and HNI tranches
| Category | Applications Reserved | Applications Received | Times Subscribed |
|---|---|---|---|
| Retail (RII) | 522,152 | 5,002,216 | 9.58x |
| HNIs (10L +) | 3,340 | 31,997 | 9.58x |
| HNIs (2-10L) | 15,984 | 153,127 | 9.58x |
| Total Applications | 541,476 | 5,187,340 | 9.58x |
Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.
Global Health Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹2,205.57 Crores. The shares are offered at a price band of ₹336 to ₹336 per equity share on NSE and BSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Following the close of bidding on 2022-11-07, the basis of allotment is scheduled to be finalized on 2022-11-11. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Kfin Technologies Limited) or the BSE allotment checking window.
The latest Grey Market Premium (GMP) for Global Health Limited IPO is ₹33 per equity share. Based on the upper price band of ₹336 to ₹336 per equity share, the estimated listing price is ₹369 (+9.8% expected listing gain).
With a lot size of 44 shares and current GMP of ₹33, the expected profit per application lot is approx ₹1,452 (+9.8% gain). Minimum application cost is approx ₹14,784.
The Global Health Limited IPO aggregate issue size is ₹2,205.57 Crores with an equity price band set at ₹336 to ₹336 per equity share. The retail lot size is 44 shares requiring a minimum capital outlay of approx. ₹14,784.
Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 9.58x (Retail: 0.00x, QIB: 0.00x, NII: 0.00x). You can track live multiples directly on our dedicated subscription page.
The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2022-11-11. Investors can verify status using PAN card or application number.
Global Health Limited shares are scheduled to list on NSE and BSE on 2022-11-16.